A client is infected with E. coli which is susceptible to gentamicin. What does gentamicin have a Black Box Warning for?

Introduction: Gentamicin is a potent aminoglycoside antibiotic used for severe aerobic gram-negative infections, but it possesses a narrow therapeutic index. The medication carries severe Black Box Warnings due to its tendency to accumulate in the renal cortex and the sensory hair cells of the inner ear. A. Aminoglycosides like gentamicin are notorious for causing permanent sensorineural hearing loss and acute tubular necrosis. The Black Box Warning alerts clinicians to the high risk of ototoxicity, which may be irreversible, and nephrotoxicity, which necessitates close monitoring of serum creatinine, BUN, and drug trough levels. B. Lactic acidosis and severe hepatomegaly with steatosis are serious metabolic complications specifically associated with nucleoside reverse transcriptase inhibitors used in HIV therapy or certain biguanides like metformin. These metabolic disturbances are not part of the toxicological profile or the Black Box Warnings associated with gentamicin therapy. C. Gastrointestinal bleeding and increased cardiovascular risks, such as myocardial infarction or stroke, are the primary Black Box Warnings associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Gentamicin does not impact platelet aggregation or cyclooxygenase pathways, so it does not carry warnings for these specific cardiovascular or gastric risks. D. While many broad-spectrum antibiotics increase the risk of Clostridioides difficile-associated colitis, this is not the primary Black Box Warning for gentamicin. Furthermore, Stevens-Johnson syndrome is a rare, life-threatening hypersensitivity reaction more commonly associated with sulfonamides, anticonvulsants, or allopurinol rather than the aminoglycoside class of antibiotics.